Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors

Biomaterials

Volumn 33, Issue 10, 2012, Pages 3025-3035

  Shan, Yuebin ^a,b   Luo, Ting ^b   Peng, Chen ^a   Sheng, Ruilong ^b   Cao, Amin ^b   Cao, Xueyan ^a   Shen, Mingwu ^a   Guo, Rui ^a   Tomás, Helena ^c   Shi, Xiangyang ^a,c  

^a DONGHUA UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

^c UNIVERSITY OF MADEIRA   (Portugal)

Author keywords

Gene delivery; Gold nanoparticles; PAMAM dendrimers; Transfection efficiency

Indexed keywords

3-DIMENSIONAL; ATOMIC FORCE; BIOMEDICAL APPLICATIONS; CELL LINES; EFFICIENT INTERACTION; ENHANCED GREEN FLUORESCENT PROTEIN; GEL-RETARDATION ASSAY; GENE DELIVERY; GENE DELIVERY VECTORS; GENE TRANSFECTION; GOLD NANOPARTICLES; MICROSCOPIC IMAGING; MOLAR RATIO; NON-VIRAL GENE DELIVERY; NONVIRAL VECTORS; PAMAM DENDRIMER; POLYAMIDOAMINE DENDRIMERS; POLYPLEXES; SPHERICAL MORPHOLOGIES; TRANSFECTION EFFICIENCY; ZETA POTENTIAL MEASUREMENTS;

BROMINE COMPOUNDS; CELL CULTURE; DENDRIMERS; EFFICIENCY; FLUORESCENCE; FUNCTIONAL POLYMERS; GENE ENCODING; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; MEDICAL APPLICATIONS; MICROSCOPIC EXAMINATION; MOLECULAR BIOLOGY; NANOPARTICLES; VECTORS; ZETA POTENTIAL;

GOLD;

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMINE; DENDRIMER; ENHANCED GREEN FLUORESCENT PROTEIN; GOLD; GOLD NANOPARTICLE; LUCIFERASE; PLASMID DNA; POLYAMIDOAMINE;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ARTICLE; ATOM; ATOMIC FORCE MICROSCOPY; CELL LINE; CHEMICAL COMPOSITION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DNA TEMPLATE; DRUG SYNTHESIS; ENZYME ASSAY; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOASSAY; IN VITRO STUDY; LIGHT SCATTERING; MOLECULAR WEIGHT; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; ZETA POTENTIAL;

AMINES; ANIMALS; CELL DEATH; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COS CELLS; DENDRIMERS; ELECTROPHORESIS, AGAR GEL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOCYTOSIS; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GOLD; HELA CELLS; HUMANS; HYDRODYNAMICS; LUCIFERASES; METAL NANOPARTICLES; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, FLUORESCENCE; PARTICLE SIZE; STATIC ELECTRICITY; TRANSFECTION; VIRUSES;

EID: 84856275170     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.12.045     Document Type: Article

References (59)

1. Zhao N., Fogg J.M., Zechiedrich L., Zu Y. Transfection of shRNA-encoding minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells. Gene Ther 2011, 18:220-224.
2. Feigin A., Kaplitt M.G., Tang C., Lin T., Mattis P., Dhawan V., et al. Modulation of metabolic brain networks after subthalamic gene therapy for parkinson's disease. Proc Natl Acad Sci U S A 2007, 104:19559-19564.
3. Kaplitt M.G. Parkinson disease: another player in gene therapy for parkinson disease. Nat Rev Neurol 2010, 6:7-8.
4. Mitomo K., Griesenbach U., Inoue M., Somerton L., Meng C., Akiba E., et al. Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with sendai virus envelopes. Mol Ther 2010, 18:1173-1182.
5. Cavazzana-Calvo M., Hacein-Bey S., Basile G.S., Gross F., Yvon E., Nusbaum P., et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000, 288:669-672.
6. Yang Z.R., Wang H.F., Zhao J., Peng Y.Y., Wang J., Guinn B.A., et al. Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. Cancer Gene Ther 2007, 14:599-615.
7. Santoso J.T., Tang D.C., Lane S.B., Hung J., Reed D.J., Muller C.Y., et al. Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol Oncol 1995, 59:171-178.
8. Li S., Huang L. Nonviral gene therapy: promises and challenges. Gene Ther 2000, 7:31-34.
9. Verma I.M., Weitzman M.D. Gene therapy: twenty-first century medicine. Annu Rev Biochem 2005, 74:711-738.
10. Guillot-Nieckowski M., Eisler S., Diederich F. Dendritic vectors for gene transfection. New J Chem 2007, 31:1111-1127.
11. Anderson W.F. Human gene therapy. Nature 1998, 392:25-30.
12. Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003, 4:346-358.
13. Mancheño-Corvo P., Martin-Duque P. Viral gene therapy. Clin Transl Oncol 2006, 8:858-867.
14. Kay M.A., Glorioso J.C., Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001, 7:33-40.
15. Luo D., Saltzman W.M. Synthetic dna delivery systems. Nat Biotechnol 2000, 18:33-37.
16. Sheridan C. Gene therapy finds its niche. Nat Biotechnol 2011, 29:121-128.
17. Medina-Kauwe L.K., Xie J., Hamm-Alvarez S. Intracellular trafficking of nonviral vectors. Gene Ther 2005, 12:1734-1751.
18. Shcharbin D.G., Klajnert B., Bryszewska M. Dendrimers in gene transfection. Biochemistry (Moscow) 2009, 74:1070-1079.
19. Paleos C.M., Tziveleka L.A., Sideratou Z., Tsiourvas D. Gene delivery using functional dendritic polymers. Expert Opin Drug Deliv 2009, 6:27-38.
20. Svenson S., Tomalia D.A. Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 2005, 57:2106-2129.
21. Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem Rev 2009, 109:259-302.
22. Dufes C., Uchegbu I.F., Sch tzlein A.G. Dendrimers in gene delivery. Adv Drug Deliv Rev 2005, 57:2177-2202.
23. Tomalia D.A., Baker H., Dewald J., Hall M., Kallos G., Martin S., et al. Anew class of polymers: starburst-dendritic macromolecules. Polym J 1985, 17:117-132.
24. Tomalia D.A., Baker H., Dewald J., Hall M., Kallos G., Martin S., et al. Dendritic macromolecules: synthesis of starburst dendrimers. Macromolecules 1986, 19:2466-2468.
25. Jain K., Kesharwani P., Gupta U., Jain N.K. Dendrimer toxicity: let's meet the challenge. Int J Pharm 2010, 394:122-142.
26. Tomalia D.A., Frechet J.M.J. Dendrimers and other dendritic polymers 2001, John Wiley & Sons, NewYork.
27. Nam H.Y., Nam K., Hahn H.J., Kim B.H., Lim H.J., Kim H.J., et al. Biodegradable pamam ester for enhanced transfection efficiency with low cytotoxicity. Biomaterials 2009, 30:665-673.
28. Haensler J., Szoka F.C. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem 1993, 4:372-379.
29. Kukowska-Latallo J.F., Bielinska A.U., Johnson J., Spindler R., Tomalia D.A., Baker J.R. Efficient transfer of genetic material into mammalian cells using starburst polyamidoamine dendrimers. Proc Natl Acad Sci U S A 1996, 93:4897-4902.
30. Fant K., Esbjorner E.K., Jenkins A., Grossel M., Lincoln P., Norden B. Effects of pegylation and acetylation of pamam dendrimers on dna binding, cytotoxicity and invitro transfection efficiency. Mol Pharmaceutics 2010, 7:1734-1746.
31. Qi R., Gao Y., Tang Y., He R.R., Liu T.L., He Y., et al. PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression. AAPS J 2009, 11:395-405.
32. He H., Li Y., Jia X.R., Du J., Ying X., Lu W.L., et al. PEGylated poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. Biomaterials 2011, 32:478-487.
33. Mishra S., Webster P., Davis M.E. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur J Cell Biol 2004, 83:97-111.
34. Gabrielson N.P., Pack D.W. Acetylation of polyethylenimine enhances gene delivery via weakened polymer/DNA interactions. Biomacromolecules 2006, 7:2427-2435.
35. Santos J.L., Oliveira H., Pandita D., Rodrigues J., Pego A.P., Granja P.L., et al. Functionalization of poly(amidoamine) dendrimers with hydrophobic chains for improved gene delivery in mesenchymal stem cells. JControl Release 2010, 144:55-64.
36. Shakhbazau A., Isayenka I., Kartel N., Goncharova N., Seviaryn I., Kosmacheva S., et al. Transfection efficiencies of PAMAM dendrimers correlate inversely with their hydrophobicity. Int J Pharm 2010, 383(1-2):228-235.
37. Santos J.L., Pandita D., Rodrigues J., Pego A.P., Granja P.L., Balian G., et al. Receptor-mediated gene delivery using pamam dendrimers conjugated with peptides recognized by mesenchymal stem cells. Mol Pharmaceutics 2010, 7:763-774.
38. Han L., Zhang A.L., Wang H.J., Pu P.Y., Jiang X.G., Kang C.S., et al. Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on u251 glioma cells invitro and invivo. Hum Gene Ther 2010, 21:417-426.
39. Duncan B., Kim C., Rotello V.M. Gold nanoparticle platforms as drug and biomacromolecule delivery systems. JControl Release 2010, 148:122-127.
40. Daniel M.C., Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 2004, 104:293-346.
41. Li D., Cui Y., Wang K., He Q., Yan X., Li J. Thermosensitive nanostructures comprising gold nanoparticles grafted with block copolymers. Adv Funct Mater 2007, 17:3134-3140.
42. Li D., He Q., Cui Y., Li J. Fabrication of pH-responsive nanocomposites of gold nanoparticles/poly(4-vinylpyridine). Chem Mater 2007, 19:412-417.
43. Li D., He Q., Cui Y., Wang K., Zhang X., Li J. Thermosensitive copolymer networks modify gold nanoparticles for nanocomposite entrapment. Chem-Eur J 2007, 13:2224-2229.
44. Li D., He Q., Li J. Smart core/shell nanocomposites: intelligent polymers modified gold nanoparticles. Adv Colloid Interface Sci 2009, 149:28-38.
45. Li D., He Q., Yang Y., Moehwald H., Li J. Two-stage pH response of poly(4-vinylpyridine) grafted gold nanoparticles. Macromolecules 2008, 41:7254-7256.
46. Ghosh P.S., Kim C.K., Han G., Forbes N.S., Rotello V.M. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano 2008, 2:2213-2218.
47. Voet D., Voet J.G. Biochemistry 1995, John Wiley & Sons, Inc, New York. 2nd ed.
48. Bosman A.W., Janssen H.M., Meijer E.W. About dendrimers: structure, physical properties, and applications. Chem Rev 1999, 99:1665-1688.
49. Imae T., Funayama K., Aoi K., Tsutsumiuchi K., Okada M., Furusaka M. Small-angle neutron scattering and surface force investigations of poly(amido amine) dendrimer with hydroxyl end groups. Langmuir 1999, 15:4076-4084.
50. Guo R., Wang H., Peng C., Shen M.W., Pan M.J., Cao X.Y., et al. X-ray attenuation property of dendrimer-entrapped gold nanoparticles. JPhys Chem C 2010, 114:50-56.
51. Shi X., Wang S., Meshinchi S., Van Antwerp M.E., Bi X., Lee I., et al. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 2007, 3:1245-1252.
52. Shi X., Wang S., Sun H., Baker J.R. Improved biocompatibility of surface functionalized dendrimer-entrapped gold nanoparticles. Soft Matter 2007, 3:71-74.
53. Shi X., Wang S.H., Lee I., Shen M., Baker J.R. Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells. Biopolymers 2009, 91:936-942.
54. Chen J., Cao X., Guo R., Shen M., Peng C., Xiao T., et al. Ahighly effective polymerase chain reaction enhancer based on dendrimer-entrapped gold nanoparticles. Analyst 2012, 137:223-228.
55. Bielinska A.U., Kukowska-Latallo J.F., Baker J.R. The interaction of plasmid dna with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed dna. Biochim Biophys Acta Gene Struct Expr 1997, 1353:180-190.
56. Putnam D. Polymers for gene delivery across length scales. Nat Mater 2006, 5:439-451.
57. Gratton S.E.A., Ropp P.A., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 2008, 105:11613-11618.
58. Jevprasesphant R., Penny J., Attwood D., McKeown N.B., D'Emanuele A. Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity. Pharm Res 2003, 20:1543-1550.
59. Kitchens K.M., Kolhatkar R.B., Swaan P.W., Eddington N.D., Ghandehari H. Transport of poly (amidoamine) dendrimers across caco-2 cell monolayers: influence of size, charge and fluorescent labeling. Pharm Res 2006, 23:2818-2826.